Free Trial
NYSE:CC

Chemours (CC) Stock Price, News & Analysis

Chemours logo
$17.13 -0.35 (-2.01%)
Closing price 03:59 PM Eastern
Extended Trading
$17.15 +0.02 (+0.12%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Chemours Stock (NYSE:CC)

Key Stats

Today's Range
$16.72
$17.32
50-Day Range
$16.69
$19.98
52-Week Range
$15.10
$29.83
Volume
2.29 million shs
Average Volume
1.75 million shs
Market Capitalization
$2.56 billion
P/E Ratio
34.26
Dividend Yield
5.84%
Price Target
$23.56
Consensus Rating
Hold

Company Overview

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Chemours Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
90th Percentile Overall Score

CC MarketRank™: 

Chemours scored higher than 90% of companies evaluated by MarketBeat, and ranked 34th out of 194 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemours has received a consensus rating of Hold. The company's average rating score is 2.44, and is based on 4 buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Chemours has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Chemours' stock forecast and price target.
  • Earnings Growth

    Earnings for Chemours are expected to grow by 71.90% in the coming year, from $1.21 to $2.08 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemours is 34.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.22.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemours is 34.29, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 99.52.

  • Price to Book Value per Share Ratio

    Chemours has a P/B Ratio of 3.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chemours' valuation and earnings.
  • Percentage of Shares Shorted

    4.90% of the float of Chemours has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemours has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Chemours has recently decreased by 0.55%, indicating that investor sentiment is improving.
  • Dividend Leadership

    Chemours is a leading dividend payer. It pays a dividend yield of 5.94%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Chemours does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Chemours is 200.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Chemours will have a dividend payout ratio of 48.08% next year. This indicates that Chemours will be able to sustain or increase its dividend.

  • Read more about Chemours' dividend.
  • Percentage of Shares Shorted

    4.90% of the float of Chemours has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemours has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Chemours has recently decreased by 0.55%, indicating that investor sentiment is improving.
  • News Sentiment

    Chemours has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 25 news articles for Chemours this week, compared to 10 articles on an average week.
  • Search Interest

    Only 5 people have searched for CC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Chemours to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemours insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.47% of the stock of Chemours is held by insiders.

  • Percentage Held by Institutions

    76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemours' insider trading history.
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Stock News Headlines

Chemours launches Ti-Pure TS-6706
The Long-Term Upside For Chemours Company After Q4 2024
I just gave away my best trading setup for free
I just held a free "Meat & Potatoes" trading workshop. I call it that because in it, I teach the exact two-step process you can use to target the most consistent trade setup I've ever seen. See one of the biggest mistakes traders make is using too many steps in their trading. Or thinking they need expensive software or a fancy indicator to target the best setups. The process I'll show you helps to eliminate both of these hurdles.
Q4 2024 Chemours Co Earnings Call Transcript
Chemours sees Q1 net sales to be flat to slightly down sequentially
See More Headlines

CC Stock Analysis - Frequently Asked Questions

Chemours' stock was trading at $16.90 at the beginning of the year. Since then, CC shares have increased by 1.4% and is now trading at $17.1450.
View the best growth stocks for 2025 here
.

The Chemours Company (NYSE:CC) issued its quarterly earnings results on Tuesday, February, 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.01. The specialty chemicals company earned $1.36 billion during the quarter, compared to analyst estimates of $1.37 billion. Chemours had a trailing twelve-month return on equity of 29.48% and a net margin of 1.34%.

Chemours' top institutional investors include Vanguard Group Inc. (10.19%), FMR LLC (9.91%), Marshall Wace LLP (4.74%) and Ameriprise Financial Inc. (2.93%). Insiders that own company stock include Sameer Ralhan, Mark Newman, Edwin C Sparks, Alisha Bellezza, Matthew S Abbott, Diane I Picho and Alvenia Scarborough.
View institutional ownership trends
.

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), AT&T (T), Tesla (TSLA), Chevron (CVX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Ex-Dividend for 12/16 Dividend
11/15/2024
Dividend Payable
12/16/2024
Last Earnings
2/18/2025
Today
2/19/2025
Ex-Dividend for 3/14 Dividend
2/28/2025
Dividend Payable
3/14/2025
Next Earnings (Estimated)
4/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Chemicals
Fax
N/A
Employees
6,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.11
High Stock Price Target
$32.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+37.8%
Consensus Rating
Hold
Rating Score (0-4)
2.44
Research Coverage
9 Analysts

Profitability

Net Income
$-238,000,000.00
Pretax Margin
0.83%

Debt

Sales & Book Value

Annual Sales
$6.03 billion
Cash Flow
$4.68 per share
Book Value
$4.98 per share

Miscellaneous

Free Float
148,709,000
Market Cap
$2.61 billion
Optionable
Optionable
Beta
1.81

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NYSE:CC) was last updated on 2/19/2025 by MarketBeat.com Staff
From Our Partners